We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$187B
AUM Growth
-$1.41B
Cap. Flow
-$15.2B
Cap. Flow %
-8.15%
Top 10 Hldgs %
24.38%
Holding
10,185
New
1,269
Increased
3,519
Reduced
3,507
Closed
1,718

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$940M
2
GLD icon
SPDR Gold Trust
GLD
+$375M
3
C icon
Citigroup
C
+$202M
4
GILD icon
Gilead Sciences
GILD
+$150M
5
M icon
Macy's
M
+$81.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.93%
2 Technology 1.75%
3 Financials 1.43%
4 Consumer Discretionary 0.87%
5 Healthcare 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLTC
2876
PUT
DELISTED
Linear Technology Corp
LLTC
$3.09M ﹤0.01%
66,400
+11,300
+21% +$516K
EAT icon
2877
PUT
Brinker International
EAT
$10B
$3.09M ﹤0.01%
+67,800
New +$3.1M
SO icon
2878
Southern Company
SO
$102B
$3.08M ﹤0.01%
57,531
-204,000
-78% -$10.3M
IQV icon
2879
CALL
IQVIA
IQV
$43.2B
$3.08M ﹤0.01%
47,200
+24,400
+107% +$1.64M
ARRS
2880
PUT
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$3.08M ﹤0.01%
147,100
+66,100
+82% +$1.5M
BSBR icon
2881
Santander
BSBR
$42.9B
$3.08M ﹤0.01%
563,945
EGRX
2882
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.08M ﹤0.01%
79,300
-55,400
-41% -$2.31M
EXP icon
2883
PUT
Eagle Materials
EXP
$6.06B
$3.07M ﹤0.01%
39,800
+8,000
+25% +$604K
IGOV icon
2884
iShares International Treasury Bond ETF
IGOV
$1.55B
$3.07M ﹤0.01%
+61,662
New +$3.03M
LNW
2885
DELISTED
Light & Wonder
LNW
$3.07M ﹤0.01%
333,681
-544,615
-62% -$5.14M
PXF icon
2886
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.99B
$3.07M ﹤0.01%
+88,760
New +$3.17M
GSK icon
2887
GSK
GSK
$101B
$3.06M ﹤0.01%
56,398
-134,257
-70% -$7.07M
SOXS icon
2888
PUT
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.26B
0
JASO
2889
CALL
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$3.05M ﹤0.01%
445,600
-52,200
-10% -$415K
MTCH icon
2890
PUT
Match Group
MTCH
$9.46B
$3.05M ﹤0.01%
202,300
+120,600
+148% +$1.58M
QLIK
2891
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$3.05M ﹤0.01%
103,093
-29,722
-22% -$886K
BRZU icon
2892
PUT
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$99.5M
$3.05M ﹤0.01%
3,314
-137
-4% -$101K
EPV icon
2893
PUT
ProShares UltraShort FTSE Europe
EPV
$9.43M
$3.04M ﹤0.01%
10,680
+3,680
+53% +$1.06M
ARRS
2894
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$3.04M ﹤0.01%
145,172
+100,104
+222% +$2.27M
DBD
2895
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
$3.04M ﹤0.01%
122,500
+10,800
+10% +$278K
VIVS
2896
PUT
VivoSim Labs
VIVS
$3.92M
$3.04M ﹤0.01%
3,406
+1,133
+50% +$760K
KLAC icon
2897
PUT
KLA
KLAC
$240B
$3.04M ﹤0.01%
415,000
-191,000
-32% -$1.37M
HRTX icon
2898
PUT
Heron Therapeutics
HRTX
$63M
$3.03M ﹤0.01%
168,100
+51,200
+44% +$1,000K
NHI icon
2899
PUT
National Health Investors
NHI
$3.56B
$3.03M ﹤0.01%
40,400
+25,700
+175% +$1.78M
OHI icon
2900
PUT
Omega Healthcare
OHI
$14B
$3.02M ﹤0.01%
89,100
+8,800
+11% +$294K

Similar funds

Jeff Yass's Q2 2016 Portfolio in Review

As of Q2 2016, Jeff Yass held 10,185 positions worth $187B, down 0.75% from $188B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass withdrew a net $15.2B in Q2 2016, closing 1,718 positions and reducing 3,507 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $700M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 90% a quarter earlier, followed by Technology and Financials.

Against the trend, Jeff Yass opened a new position in Vanguard Long-Term Bond ETF worth $47.5M.

  • Jeff Yass's largest Q2 2016 buy was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M.
  • Jeff Yass added most to Apple in Q2 2016, an estimated $940M increase.
  • Jeff Yass's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.28B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ETF in Q2 2016, selling an estimated $700M.
  • Jeff Yass's ten largest holdings make up 24% of its $187B portfolio in Q2 2016.
  • Jeff Yass opened 1,269 new positions and closed 1,718 in Q2 2016.
  • Jeff Yass's portfolio value fell 0.75% quarter-over-quarter to $187B.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.